Loading insider details...
Beta
Latest Form 4 (Mar 7, 2024): Disposition to Issuer of 17,857 AMAM shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Mar 7, 2024 | Ambrx Biopharma, Inc. (AMAM) | Disposition to Issuer | 17,857 | n/a |
| Mar 4, 2024 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 35,000 | n/a |
| Jan 8, 2024 | SEELOS THERAPEUTICS, INC. (SEEL) | Grant/Award | 1,666 | n/a |
| Nov 7, 2023 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 14,110 | n/a |
| Aug 29, 2023 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 1,472,692 | n/a |
| Jan 9, 2023 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 250,000 | n/a |
| Sep 16, 2021 | Skye Bioscience, Inc. (SKYE) | Grant/Award | 150,000 | n/a |
| Aug 12, 2020 | Emerald Bioscience, Inc. (EMBI) | Grant/Award | 250,000 | n/a |